China Resources Medical Holdings Company Limited

HKEX:1515.HK

3.68 (HKD) • At close September 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q4
Revenue 4,878.4564,976.3344,993.4745,114.0264,695.3553,205.9322,675.3541,772.1231,843.237907.4131,150.381964.9391,143.361916.1171,015.606862.118827.631705.2770.002602.265699.299506.966467.662419.692221.839379.016189.508
Cost of Revenue 4,104.9783,939.9864,177.1284,024.7513,994.9992,600.4722,136.3731,377.5491,452.053662.09733.653619.376744.753558.047670.478539.009603.072523.126581.975460.711520.945387.617342.392332.268168.665286.614143.307
Gross Profit 773.4781,036.348816.3461,089.275700.356605.46538.981394.574391.184245.323416.728345.563398.608358.07345.128323.109224.559182.074188.027141.554178.354119.349125.2787.42453.17492.40246.201
Gross Profit Ratio 0.1590.2080.1630.2130.1490.1890.2010.2230.2120.270.3620.3580.3490.3910.340.3750.2710.2580.2440.2350.2550.2350.2680.2080.240.2440.244
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 577.014471.578522.744448.025496.228312.433278.943188.692212.33106.803127.189107.008110.07193.471108.31178.2494.35953.57596.26643.0542.85334.51840.67525.10716.44621.7510.875
Selling & Marketing Expenses 1.8152.4382.555.27810.7538.7798.6378.1458.3216.2649.176.96510.9238.96515.8919.22113.75210.3762.3838.2223.0335.1813.6044.7472.0883.2061.603
SG&A 575.543473.672595.585457.621539.532324.744369.842196.034245.33113.067139.596113.973120.994102.436124.20287.461108.11163.95198.64951.27245.88639.69944.27929.85418.53324.95612.478
Other Expenses 0000000000000000000000-0.219-0.113-0.113-0.075-0.038
Operating Expenses 575.543473.672595.585464.112597.798325.775570.691156.396171.846112.005154.853115.214120.616108.16213.84952.3211,851.15146.256101.08829.0888.60921.47535.3959.73918.42124.88112.441
Operating Income 197.935562.676220.761631.69168.588281.01169.139198.54145.854132.256277.132231.59277.614255.634220.926235.648116.448118.12389.37890.282132.46879.6580.99157.5743.0175.99537.997
Operating Income Ratio 0.0410.1130.0440.1240.0360.0880.0630.1120.0790.1460.2410.240.2430.2790.2180.2730.1410.1680.1160.150.1890.1570.1730.1370.1940.2010.201
Total Other Income Expenses Net 13.40764.652-352.966-6.564-51.84433.245-168.80671.602116.1423.93510.22622.35131.40824.287-58.988161.921-1,723.39136.33920.53447.77468.91635.725-8.14312.591-7.258-2.356-1.178
Income Before Tax 211.342627.328-132.205625.126108.98313.9610.333270.142261.994156.191287.358253.941309.022279.921161.938397.569-1,606.943154.462109.912138.056201.384115.37572.84870.16135.75273.63936.82
Income Before Tax Ratio 0.0430.126-0.0260.1220.0230.09800.1520.1420.1720.250.2630.270.3060.1590.461-1.9420.2190.1430.2290.2880.2280.1560.1670.1610.1940.194
Income Tax Expense 51.25115.67326.773138.25851.29543.365220.20664.81751.89345.97175.24865.41776.11373.27463.26666.54627.79419.53741.71633.83846.95830.27229.1217.74511.71618.2729.136
Net Income 131.926433.949-139.997397.67721.186244.669218.6199.315202.378107.753207.744183.121228.908201.9996.11324.924-1,637.276130.31265.419101.626147.66782.38439.63850.35424.03655.36727.684
Net Income Ratio 0.0270.087-0.0280.0780.0050.0760.0820.1120.110.1190.1810.190.20.220.0950.377-1.9780.1850.0850.1690.2110.1630.0850.120.1080.1460.146
EPS 0.10.34-0.110.310.0170.190.170.160.160.0860.160.150.180.160.0750.25-1.670.160.0760.120.180.0990.0620.0990.0420.0660.033
EPS Diluted 0.10.34-0.110.310.0170.190.170.160.160.0860.160.150.180.160.0750.25-1.670.160.080.120.180.0990.0620.0990.0420.0660.033
EBITDA 471.668840.132519.056892.294436.92445.821270.983256.924199.305173.274303.966262.489316.146286.715254.96264.961140.847141.365111.309109.613150.81197.10296.62274.98152.13794.07747.038
EBITDA Ratio 0.0970.1690.1040.1740.0930.1390.1010.1450.1080.1910.2640.2720.2770.3130.2510.3070.170.20.1450.1820.2160.1920.2070.1790.2350.2480.248